Bonus Biogroup (BONS) — Long-term Investment Intensity

Latest as of December 2010: 14.8%

Bonus Biogroup (BONS) has a Long-term Investment Intensity of 14.8% as of December 2010. Long-term investments of ILA900.00K represent 14.8% of total assets of ILA6.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Bonus Biogroup book value and equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

14.8%
LT Investments / Total Assets

Long-term Investments

ILA900.00K
ILA

Total Assets

ILA6.07 Million
ILA

Country

Israel
TA

Bonus Biogroup Long-term Investment Intensity (2008–2010)

This chart shows how Bonus Biogroup's Long-term Investment Intensity has evolved across 2 annual periods from 2008 to 2010. As of December 2010, the intensity stands at 14.8%, reflecting long-term investments of ILA900.00K against total assets of ILA6.07 Million ILA. Also explore BONS total asset value for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Bonus Biogroup (2008–2010)

The table below presents the year-by-year Long-term Investment Intensity for Bonus Biogroup from 2008 to 2010, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BONS market cap overview.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2010 14.8% ILA900.00K ILA6.07 Million ▲ +13.0 pp
2008 1.8% ILA935.00K ILA50.81 Million
pp = percentage points